… to immune checkpoint inhibitors than patients with low HLA-I … HLAs presents tumor antigens
to T cells to facilitate the … class II molecules expression were induced on certain tumor cells …

… such as immune checkpoint inhibition, therapeutic vaccines, … HLA-I molecules present
peptides derived from … be explained by differential induction of surface and soluble HLA-G, …

… by tightly bound peptides derived from proteins degraded … ability of tumor cells to process
and present tumor antigens to … BRAF inhibitor vemurafenib strengthens the induction of HLA …

… A1-restricted antigenic peptides, which exhibited prominent inhibiting … tumor antigens (a
“non-self” component) into the body, the antitumor effect can be initiated, which is mainly caused …

… Defects in human leukocyte antigen (HLA) class I antigen-… of HLA class I antigen/tumor
antigen–derived peptide … protein (MAVS) by inducing transcription and cytoplasmic translocation …

… and other types of tumor antigens has mainly focused on MHC class I molecule-restricted
antigens (106). However, … In addition, HLA-G can also inhibit the secretion of cytokines, induce …

… , affinity of the peptides to human leukocyte antigen-A2 (HLA-A2) … that increased expression
of tumor antigens would improve the … Importantly, an obvious inhibition in tumor growth was …

… Cytotoxic T lymphocyte (CTL) epitopes derived from tumour antigens … -induced upregulation
of p38 phosphorylation level, we found that in DCs treated with TAK242 (a specific inhibitor …

… -G) is a potent regulatory protein involved in the induction of … also within the tumor, such as
eg the loss of tumor antigens, … by therapeutic HLA-G inhibition in HLA-G expressing tumors (…

… induction of G1 cell cycle arrest [34]. In CML, targeting the peroxisome proliferator-activated
receptor alpha and gamma led to growth inhibition … used for MHC-I antigen presentation [36, …